OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 70 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $201,000 | -2.4% | 40,884 | -1.4% | 0.00% | – |
Q3 2016 | $206,000 | -2.8% | 41,484 | -0.5% | 0.00% | – |
Q2 2016 | $212,000 | -8.2% | 41,684 | +3.2% | 0.00% | – |
Q1 2016 | $231,000 | -37.1% | 40,408 | +14.3% | 0.00% | -100.0% |
Q4 2015 | $367,000 | -42.7% | 35,356 | +1.8% | 0.00% | -50.0% |
Q3 2015 | $641,000 | -5.5% | 34,731 | -0.3% | 0.00% | 0.0% |
Q2 2015 | $678,000 | +11.9% | 34,831 | +1.0% | 0.00% | +100.0% |
Q1 2015 | $606,000 | +7.6% | 34,485 | -2.0% | 0.00% | 0.0% |
Q4 2014 | $563,000 | +27.7% | 35,185 | +0.4% | 0.00% | 0.0% |
Q3 2014 | $441,000 | -18.5% | 35,035 | +1.2% | 0.00% | 0.0% |
Q2 2014 | $541,000 | +37.3% | 34,636 | +15.3% | 0.00% | 0.0% |
Q1 2014 | $394,000 | -18.4% | 30,036 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $483,000 | -2.6% | 30,036 | +0.7% | 0.00% | 0.0% |
Q3 2013 | $496,000 | +70.4% | 29,836 | +3.1% | 0.00% | 0.0% |
Q2 2013 | $291,000 | -1.7% | 28,929 | +1.5% | 0.00% | 0.0% |
Q1 2013 | $296,000 | – | 28,509 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 1,579,561 | $19,887,000 | 2.73% |
PRINCETON CAPITAL MANAGEMENT INC | 35,825 | $451,000 | 0.29% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 388,039 | $4,885,000 | 0.18% |
ELLINGTON MANAGEMENT GROUP LLC | 15,700 | $198,000 | 0.14% |
Baker Brothers Advisors | 510,606 | $6,429,000 | 0.08% |
Rodgers Brothers Inc. | 10,400 | $131,000 | 0.07% |
Nine Chapters Capital Management LLC | 31,800 | $400,000 | 0.04% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 71,037 | $895,000 | 0.02% |
KILLEN GROUP INC | 34,600 | $436,000 | 0.02% |
Freedom Investment Management, Inc. | 10,591 | $133,000 | 0.02% |